Combination ACE inhibitor therapy raises risk of kidney failure, death
March 22nd, 2011 - 5:27 pm ICT by ANIWashington, Mar 22 (ANI): A new study has warned that elderly patients who have been prescribed combination angiotensin converting enzyme (ACE) inhibitors and angiotensin receptor blockers (ARB) have a higher risk of kidney failure and death.
This study, by researchers from the University of Alberta and the University of Calgary, sought to determine the safety of combination therapy of ACE inhibitors and ARB in the clinical setting as some randomized trials indicate an increased risk of kidney failure.
The researchers looked at 32 312 seniors in Alberta, Canada, aged 65 and older who were prescribed an ACE inhibitor and/or an ARB. They compared patients receiving both drugs together with patients who received only one of the drugs. They found a higher risk of adverse events such as high creatinine levels, end-stage renal disease and death in people taking combination therapy.
“We found that less than one-seventh of the elderly residents of Alberta who were given combination therapy in clinical practice had either of the conditions for which this therapy has been proven beneficial in randomized trials (i.e., proteinuria or symptomatic left ventricular systolic dysfunction despite treatment with and ACE inhibitor or an angiotensin-receptor blocker alone,” said Dr. Finlay McAlister, University of Alberta, with co-authors.
As well, they observed that within three months, most patients stopped the combination therapy. The authors speculate this may have been due to low blood pressure.
The study is published in CMAJ (Canadian Medical Association Journal). (ANI)
- Patients receiving dialysis 'at higher risk for sudden cardiac death' - Nov 15, 2010
- Blood pressure medications show higher cancer risk: Study - Jun 14, 2010
- Study links Blood pressure drugs to cancer - Jun 15, 2010
- BP drugs may cut dementia risk - Jan 13, 2010
- Popular cancer drug can lead to kidney damage - Jun 11, 2010
- BP drug could harm stroke patients - Feb 13, 2011
- BP drug not tied to death risk among heart patients - Apr 11, 2012
- Common Blood Pressure Drugs May Amplify The Risk Of Cancer - Jun 15, 2010
- New drug reduces reduces risk of heart attack, strokes - Sep 01, 2008
- Blood Pressure Drugs Increase Cancer Risk, Study Reveals - Jun 15, 2010
- BP lowering drug reduces heart attack risk - Sep 01, 2008
- Singing lowers patient's BP prior to surgery - Mar 31, 2011
- Can proteins in blood predict early death? - Dec 16, 2011
- Beta-blockers for heart patients a double-edged sword - Nov 22, 2009
- Novel approach offers new insights into causes of pre-eclampsia - Oct 07, 2010
Tags: ace inhibitor, ace inhibitors, angiotensin receptor blocker, arb, canadian medical association, canadian medical association journal, combination therapy, dr finlay, elderly residents, finlay mcalister, high creatinine levels, kidney failure, left ventricular systolic dysfunction, low blood pressure, medical association journal, randomized trials, receptor blockers, renal disease, university of alberta, university of calgary